SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

Wong, Deysi Viviana Tenazoa ; Ribeiro-Filho, Helder Veras ; Wanderley, Carlos Wagner Souza ; Leite, Caio Abner Vitorino Gonçalves ; Lima, Jonilson Berlink ; Assef, Alexia Nathália Brígido ; Cajado, Aurilene Gomes ; Batista, Gabriela Loiola Ponte ; González, Rafael Holanda ; Silva, Karla Oliveira ; Borges, Luis Philipi Carvalho ; Alencar, Nylane Maria Nunes ; Wilke, Diego Veras ; Cunha, Thiago Mattar ; Figueira, Ana Carolina Migliorini ; Cunha, Fernando Queiroz ; Lima-Júnior, Roberto César Pereira

Cancer chemotherapy and pharmacology, 2019-08, Vol.84 (2), p.287-298 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível